APA

Parise R. A., Beumer J. H., Clausen D. M., Rigatti L. H., Ziegler J. A., Gasparetto M., Smith C. A. & Eiseman J. L. (20140130). Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice. : Cancer chemotherapy and pharmacology.

Chicago

Parise Robert A, Beumer Jan H, Clausen Dana M, Rigatti Lora H, Ziegler Judy A, Gasparetto Maura, Smith Clayton A and Eiseman Julie L. 20140130. Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice. : Cancer chemotherapy and pharmacology.

Harvard

Parise R. A., Beumer J. H., Clausen D. M., Rigatti L. H., Ziegler J. A., Gasparetto M., Smith C. A. and Eiseman J. L. (20140130). Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice. : Cancer chemotherapy and pharmacology.

MLA

Parise Robert A, Beumer Jan H, Clausen Dana M, Rigatti Lora H, Ziegler Judy A, Gasparetto Maura, Smith Clayton A and Eiseman Julie L. Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice. : Cancer chemotherapy and pharmacology. 20140130.